news

Latest News

View All

Product Briefs: Personal Genome Diagnostics

Personal Genome Diagnostics (PGDx), of Baltimore,reported an expansion of its cancer testing contract with theU.S. Department of Veterans Affairs that replaces an earliertumor profiling assay with the company’s new Cancerselect 125test. Cancerselect 125 is a comprehensive, clinically actionablepan-cancer profiling test that includes microsatellite instabilitystatus, a biomarker used to assess potential patient response…

Personal Genome Diagnostics Expands Cancer Testing Contract With Veterans Affairs

 NEW YORK (GenomeWeb) – Personal Genome Diagnostics announced today that its cancer testing contract with the US Department of Veterans Affairs has been amended to include its CancerSelect 125 test for pan-cancer tumor profiling.In early 2015, the company signed an agreement to provide the VA with its CancerSelect cancer gene panel, which…

Expansion of Cancer Testing Contract With Veterans Affairs

Mar 22, 2017NEW YORK (GenomeWeb) – Personal Genome Diagnostics announced today that its cancer testing contract with the US Department of Veterans Affairs has been amended to include its CancerSelect 125 test for pre-cancer tumor profiling.In early 2015, the company signed an agreement to provide the VA with its CancerSelect cancer gene…